Drugs / Nafithromycin
Nafithromycin
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT03981887 | Jun → Jul 2019 | — | Wockhardt | Completed | No outcome recorded |
| Phase 1 | NCT02770404 | Apr → Oct 2016 | — | Wockhardt | Completed | No outcome recorded |
| Phase 1 | NCT02453529 | Apr → Jul 2015 | — | Wockhardt | Completed | No outcome recorded |
| Phase 1 | NCT03979859 | Aug → Dec 2013 | — | Wockhardt | Completed | No outcome recorded |
| Phase 1 | NCT03926962 | Mar → Jun 2013 | — | Wockhardt | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02903836 | Nov 2016 → Jul 2017 | bacterial pneumonia | Wockhardt | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nafithromycin | “Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.” PMID 28696231 ↗ Aug 2017 |
| Known as | Nafithromycine | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297519 ↗ |
| Known as | Nafitromicina | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297519 ↗ |
| Known as | WCK 4873 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02453529 ↗ |
| Modality | Small molecule | — CHEMBL4297519 ↗ |
| Route | Intravenous | “Intravenous Nafithromycin” NCT02770404 ↗ |